Earnings History Data for Autolus Therapeutics plc (AUTL) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Autolus Therapeutics plc
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies. The company's pipeline of product candidate involved in development for the treatment of haematological malignancies and solid tumours. Autolus Therapeutics plc is based in London, United Kingdom.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-03-2024 | PM | AUTL | Autolus Therapeutics plc | 937.80 | -0.44 | -0.26 | -0.23 | Autolus Therapeutics GAAP EPS of -$1.20 misses by $0.10, revenue of $1.69M misses by $0.01M [3/14/2024 7:02 AM] |
5.68 | 0.20 (3.65%) |
0.0 | 0.0 (0.00%) |
1.61 - 7.45 | 2,856,559 | 1,180,000 | 0 | ||
| 02-11-2023 | PM | AUTL | Autolus Therapeutics plc | 488.07 | -0.26 | -0.24 | -0.47 | Autolus Therapeutics GAAP EPS of -$0.26 in-line [11/2/2023 7:22 AM] |
3.39 | 0.44 (14.92%) |
2.95 | 0.0 (0.00%) |
1.60 - 3.53 | 1,653,494 | 460,000 | 5,196 | ||
| 03-08-2023 | PM | AUTL | Autolus Therapeutics plc | 545.18 | -0.26 | -0.22 | -0.46 | Autolus Therapeutics GAAP EPS of -$0.26 misses by $0.03 [8/3/2023 7:11 AM] |
3.00 | -0.13 (-4.15%) |
0.0 | 0.0 (0.00%) |
1.60 - 3.79 | 338,897 | 530,000 | 0 | ||
| 07-03-2023 | PM | 7:00 AM ET (Mar 7) |
AUTL | Autolus Therapeutics plc | 334.00 | -0.23 | -0.37 | -0.51 | Autolus Therapeutics GAAP EPS of -$1.57 beats by $0.06, revenue of $6.36M misses by $4.47M [3/7/2023 7:06 AM] |
1.93 | 0.02 (1.05%) |
1.93 | 0.02 (1.05%) |
1.60 - 4.73 | 550,120 | 310,000 | 9,027 | |
| 03-11-2022 | PM | 7:00 AM ET (Nov 3) |
AUTL | Autolus Therapeutics plc | 264.55 | -0.47 | -0.46 | -0.47 | Autolus Therapeutics GAAP EPS of -$0.47 in-line, revenue of $2.37M beats by $2.23M [11/3/2022 7:04 AM] |
2.63 | -0.15 (-5.40%) |
0.0 | 0.0 (0.00%) |
1.96 - 7.90 | 335,518 | 90,000 | 0 | |
| 04-08-2022 | PM | 7:00 AM ET (Aug 4) |
AUTL | Autolus Therapeutics plc | 260.03 | -0.46 | -0.42 | -0.47 | Autolus Therapeutics GAAP EPS of -$0.46 misses by $0.13 [8/4/2022 7:12 AM] |
3.27 | 0.48 (17.20%) |
3.92 | -0.40 (-9.26%) |
1.96 - 7.90 | 224,367 | 100,000 | 51,552 | |
| 05-05-2022 | PM | 7:00 AM ET (May 5) |
AUTL | Autolus Therapeutics plc | 294.54 | -0.41 | -0.51 | -0.53 | Autolus Therapeutics GAAP EPS of -$0.41 beats by $0.07, revenue of $0.17M in-line [5/5/2022 7:24 AM] |
3.26 | 0.05 (1.50%) |
3.20 | -0.01 (-0.31%) |
3.00 - 8.23 | 171,532 | 220,000 | 10,234 | |
| 10-03-2022 | PM | 7:00 AM ET (Mar 10) |
AUTL | Autolus Therapeutics plc | 271.99 | -0.51 | -0.50 | -0.82 | Autolus Therapeutics GAAP EPS of -$1.97 misses by $0.08, revenue of $2.33M misses by $4.87M [3/10/2022 7:05 AM] |
4.74 | 0.20 (4.41%) |
3.71 | -0.13 (-3.39%) |
3.54 - 8.23 | 474,953 | 570,211 | 801 | |
|
||||||||||||||||||
| 03-11-2021 | PM | 7:00 AM ET (Nov 3) |
AUTL | Autolus Therapeutics plc | 418.27 | -0.47 | -0.50 | -0.72 | Autolus Therapeutics EPS beats by $0.04, misses on revenue [11/3/2021 7:37 AM] |
5.95 | 0.41 (7.40%) |
5.62 | 0.08 (1.44%) |
4.60 - 12.29 | 720,906 | 200,000 | 3,553 | |
| 05-08-2021 | PM | 7:00 AM ET (Aug 5) |
AUTL | Autolus Therapeutics plc | 391.04 | -0.47 | -0.50 | -0.62 | Autolus Therapeutics EPS beats by $0.04, beats on revenue [8/5/2021 7:15 AM] |
5.95 | 0.18 (3.03%) |
5.65 | -0.12 (-2.08%) |
4.60 - 16.78 | 1,810,170 | 2,880,000 | 32,258 | |
| 06-05-2021 | PM | 7:00 AM ET (May 6) |
AUTL | Autolus Therapeutics plc | 377.92 | -0.53 | -0.62 | -0.60 | Autolus Therapeutics EPS beats by $0.11, misses on revenue [5/6/2021 7:02 AM] |
5.10 | -0.10 (-1.92%) |
5.10 | 0.0 (0.00%) |
4.94 - 17.19 | 825,759 | 700,000 | 4,655 | |
| 04-03-2021 | PM | 7:00 AM ET (Mar 4) |
AUTL | Autolus Therapeutics plc | 479.03 | -0.82 | -0.75 | -0.93 | Autolus Therapeutics EPS misses by $0.10, beats on revenue [3/4/2021 7:09 AM] |
6.21 | -0.20 (-3.12%) |
6.40 | -0.01 (-0.16%) |
3.00 - 17.19 | 1,275,142 | 1,050,245 | 4,731 | |
| 05-11-2020 | PM | 7:00 AM ET (Nov 5) |
AUTL | Autolus Therapeutics plc | 593.56 | -0.72 | -0.66 | -0.61 | Autolus Therapeutics EPS misses by $0.02 [11/5/2020 7:16 AM] |
12.01 | 0.07 (0.59%) |
11.94 | 0.0 (0.00%) |
3.00 - 17.19 | 57,812 | 98,044 | 376 | |
|
|
||||||||||||||||||
| 06-08-2020 | PM | 7:00 AM ET (Aug 6) |
AUTL | Autolus Therapeutics plc | 729.88 | -0.62 | -0.70 | -0.65 | Autolus Therapeutics EPS beats by $0.10, misses on revenue [8/6/2020 7:12 AM] |
15.82 | 0.79 (5.26%) |
15.03 | 0.0 (0.00%) |
3.00 - 17.19 | 125,766 | 251,750 | 458 | |
|
|
||||||||||||||||||